Clearline Capital »

Cytokinetics shares owned by Clearline Capital

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Clearline Capital from 13F filings

Historical chart of Clearline Capital investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Clearline Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Clearline Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.4M 48k 70.11